Loading
Latest filing published 28 May 2021 for Genesis Healthcare, Inc., €9,299.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
JoAnne Susan Reifsnyder is a declared insider of Genesis Healthcare, Inc. (chief executive), with filings sourced from SEC (Form 4). In total, 17 filings cover trades dated from 3 June 2015 to 15 May 2021.
Every open-market trade on record is a sale: 10 sales worth €77k. The rest of the record consists of 7 share grants.
On 28 May 2021 came the latest disclosure, a share grant for €9,299 in Genesis Healthcare, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration